Table 1 The demographic, clinical, biochemical, and radiological characteristics of all cirrhotic patients with and without HCC who had PVT or did not develop PVT after a year
From: Diagnosis of portal vein thrombosis in cirrhotic patients with and without hepatocellular carcinoma
Variables | Group of cirrhosis without HCC (n = 47) | P value | Group cirrhosis with HCC (n = 44) | P value | Total patients of cirrhosis (n=91) | P value | |||
|---|---|---|---|---|---|---|---|---|---|
PVT (n = 6) | No PVT (n =41) | PVT (n =10) | No PVT (n = 34) | PVT (n = 16) | No PVT (n = 75) | ||||
ALT | 60.00±8.71 | 51.00±21.35 | 0.489 (NS) | 59.20±13.16 | 51.46±20.53 | 0.444 (NS) | 59.50± 10.99 | 51.21± 20.63 | 0.283 (NS) |
AST | 68.33±12.22 | 65.35±36.99 | 0.894 (NS) | 68.20±17.10 | 66.67±21.46 | 0.887 (NS) | 68.25± 14.48 | 65.96± 30.25 | 0.838 (NS) |
ALKP | 128.01±56.82 | 113.76±33.20 | 0.542 (NS) | 110.40±35.87 | 98.13±49.14 | 0.616 (NS) | 117 ± 41.72 | 106.43 ± 41.50 | 0.524 (NS) |
GGT | 66.33±21.01 | 55.45±18.89 | 0.376 (NS) | 63.20±9.67 | 54.40±36.20 | 0.604 (NS) | 64.37 ± 13.50 | 54.95 ± 27.86 | 0.362 (NS) |
PT | 19.27±4.64 | 18.79±5.91 | 0.898 (NS) | 18.12±3.14 | 18.11±4.11 | 0.998(NS) | 18.55 ± 3.48 | 18.47 ± 5.07 | 0.969 (NS) |
INR | 1.62±0.49 | 1.61±0.61 | 0.985 (NS) | 1.53±0.29 | 1.56±0.43 | 0.873 (NS) | 1.56 ± 0.34 | 1.59 ± 0.52 | 0.892 (NS) |
Albumin | 2.50±0.50 | 2.25±0.86 | 0.639 (NS) | 2.36±0.75 | 2.83±0.71 | 0.221 (NS) | 2.41 ± 0.63 | 2.53 ± 0.84 | 0.724 (NS) |
T. bilirubin | 4.13±2.15 | 3.09±3.78 | 0.655 (NS) | 2.69±1.33 | 2.99±3.18 | 0844 (NS) | 3.23 ± 1.69 | 3.06 ± 3.05 | 0.883 (NS) |
Platelet count (×103/cm2) | 73.00±22.00 | 111.52±33.18 | 0.041 (S) | 85.60±20.03 | 108.60±16.80 | 0.021 (S) | 80.87 ± 20.25 | 110.15 ± 26.42 | 0.006 (HS) |
Annexin V (ng/ml) | 4.88±2.08 | 3.5±1.07 | 0.01 (HS) | 6.28±1.78 | 3.73±1.1 | 0.001 (HS) | 5.75 ±1.96 | 3.63 ±1.08 | <0.001 (HS) |
Portal flow velocity (cm/s) | 10.33±1.53 | 18.22±4.14 | 0.005 (HS) | 10.80±1.64 | 16.53±3.31 | 0.002 (HS) | 10.63 ± 1.50 | 17.43 ± 3.81 | <0.001 (HS) |